Clinical Trial Update: Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma [Phase 2]

View source ↗

Summary

This Clinical Trial Update describes a Phase 2 neoadjuvant trial of adebrelimab plus chemoradiotherapy for locally advanced thymic carcinoma. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Thymic Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING